Kodur, Nandan
Tang, W. H. Wilson
Article History
Accepted: 18 April 2024
First Online: 20 May 2024
Compliance with Ethical Standards
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Mr. Kodur declares no competing interests. Dr. Tang reports that he is a consultant for Sequana Medical, Cardiol Therapeutics, Genomics plc, Zehna Therapeutics, WhiteSwell, Boston Scientific, CardiaTec Biosciences, Intellia Therapeutics, Bristol Myers Squibb, Alleviant Medical, Alexion Pharmaceuticals, Salubris Biotherapeutics, and has received honorarium from Springer, Belvoir Media Group, and American Board of Internal Medicine (payments to him directly).